KaloBios Pharmctcls (KBIO)

KaloBios (KBIO) Crumbles: Shkreli Arrested & Fired, Delisted And Board Members Quit

KaloBios, the relatively unknown penny stock pharma company, which was on the verge of bankruptcy, hit the headlines after controversial figure Martin Shkreli took a large stake in the company and became its CEO, is falling apart as managers flee the sinking ship.

Prior to Shkreli's investment, at the beginning of December, KaloBios was running out of cash fast and had planned to shut down before the end of the year. However, Shkreli rode to the rescue of KaloBios with a $8.2 million . . .


This content is exclusively for paying members. Access all of our content on including years of timeless investment news and in depth analysis for only a few dollars a month by signing up here while also supporting quality content and journalism, or learn more about our premium content here

If you are subscribed and having an account error please clear cache and then cookies if that does not work email support@valuewalk.com and we will get back to you as quick as humanly possible

Subscribe to our mailing list

* indicates required

Opt out of occasional 3rd party offers